Reply to "Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et al"

M Ostergaard; B Baslund; W Rigby; B Rojkovich; C Jorgensen; P T Dawes; Charlotte Wiell; D J Wallace; S C Tamer; H Kastberg; J Petersen; S Sierakowski; Mikkel Østergaard; Bo Baslund

doi:http://dx.doi.org/10.1002/art.30097

Reply to "Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et al"

M Ostergaard, B Baslund, W Rigby, B Rojkovich, C Jorgensen, P T Dawes, Charlotte Wiell, D J Wallace, S C Tamer, H Kastberg, J Petersen, S Sierakowski, Mikkel Østergaard, Bo Baslund

Abstract

Udgivelsesdato: 2011-Jan

Originalsprog	Engelsk
Tidsskrift	Arthritis & Rheumatism
Vol/bind	63
Udgave nummer	1
Sider (fra-til)	305
Antal sider	1
ISSN	0004-3591
DOI	https://doi.org/10.1002/art.30097
Status	Udgivet - 2011

Adgang til dokumentet

http://dx.doi.org/10.1002/art.30097

Citationsformater

Ostergaard, M., Baslund, B., Rigby, W., Rojkovich, B., Jorgensen, C., Dawes, P. T., Wiell, C., Wallace, D. J., Tamer, S. C., Kastberg, H., Petersen, J., Sierakowski, S., Østergaard, M., & Baslund, B. (2011). Reply to "Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et al". Arthritis & Rheumatism, 63(1), 305. https://doi.org/10.1002/art.30097

Ostergaard, M, Baslund, B, Rigby, W, Rojkovich, B, Jorgensen, C, Dawes, PT, Wiell, C, Wallace, DJ, Tamer, SC, Kastberg, H, Petersen, J, Sierakowski, S, Østergaard, M & Baslund, B 2011, 'Reply to "Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et al"', Arthritis & Rheumatism, bind 63, nr. 1, s. 305. https://doi.org/10.1002/art.30097

@article{2b5b3827bcc349a79f3616f93615ec52,

title = "Reply to {"}Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by {\O}stergaard et al{"}",

abstract = "Udgivelsesdato: 2011-Jan",

author = "M Ostergaard and B Baslund and W Rigby and B Rojkovich and C Jorgensen and Dawes, {P T} and Charlotte Wiell and Wallace, {D J} and Tamer, {S C} and H Kastberg and J Petersen and S Sierakowski and Mikkel {\O}stergaard and Bo Baslund",

year = "2011",

doi = "http://dx.doi.org/10.1002/art.30097",

language = "English",

volume = "63",

pages = "305",

journal = "Arthritis & Rheumatology",

issn = "2326-5205",

publisher = "Wiley",

number = "1",

}

TY - JOUR

T1 - Reply to "Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et al"

AU - Ostergaard, M

AU - Baslund, B

AU - Rigby, W

AU - Rojkovich, B

AU - Jorgensen, C

AU - Dawes, P T

AU - Wiell, Charlotte

AU - Wallace, D J

AU - Tamer, S C

AU - Kastberg, H

AU - Petersen, J

AU - Sierakowski, S

AU - Østergaard, Mikkel

AU - Baslund, Bo

PY - 2011

Y1 - 2011

N2 - Udgivelsesdato: 2011-Jan

AB - Udgivelsesdato: 2011-Jan

U2 - http://dx.doi.org/10.1002/art.30097

DO - http://dx.doi.org/10.1002/art.30097

M3 - Letter

SN - 2326-5205

VL - 63

SP - 305

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - 1

ER -